Secondary analysis of baseline data from the MEL-SELF RCT (504 adults previously treated for early-stage melanoma): skin self-examination varied widely (20% none in 12 months) and 46% reported clinically significant fear of cancer recurrence.
Secondary analysisn = 504
Medcalf et al. Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance Trial